Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Semmler

Showing results (71-80 of 196) with videos related to

Pageof 20
Sort By:
Journal of Clinical Medicine|February 11, 2021
Long-Term Technical Performance of the Osypka QT-5<sup>®</sup> Ventricular Pacemaker LeadGeorg Semmler, Fabian Barbieri, Karin Thudt, et al.
Journal of Personalized Medicine|April 3, 2021
PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary CenterGeorg Semmler, Lorenz Balcar, Hannes Oberkofler, et al.
Endocrine|September 16, 2025
Association of leptin levels and relative leptin deficiency with steatotic liver disease in the general populationBernhard Wernly, Marianna Beghini, Georg Semmler, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 15, 2021
PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary centerLorenz Balcar, Georg Semmler, Hannes Oberkofler, et al.
Open Heart|March 12, 2026
Association of Life's Simple 7 with metabolic-associated steatotic liver disease and non-invasive fibrosis markersHannah Hofer, Sarah Wernly, Georg Semmler, et al.
Plos One|April 13, 2021
Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver diseaseMichael Eder, Haris Omic, Jana Gorges, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2020
Sequential systemic treatment in patients with hepatocellular carcinomaMartha M Kirstein, Bernhard Scheiner, Tristan Marwede, et al.
Hepatology International|February 9, 2024
FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defenceBenedikt Simbrunner, Benedikt S Hofer, Philipp Schwabl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2023
Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosisBenedikt Silvester Hofer, Benedikt Simbrunner, Lukas Hartl, et al.
Nutrients|July 11, 2023
Inadequate Energy Delivery Is Frequent among COVID-19 Patients Requiring ECMO Support and Associated with Increased ICU MortalityMathias Schneeweiss-Gleixner, Bernhard Scheiner, Georg Semmler, et al.
Pageof 20

Showing results (71-80 of 196) with videos related to

Sort By:
Pageof 20
Journal of Clinical Medicine|February 11, 2021
Long-Term Technical Performance of the Osypka QT-5<sup>®</sup> Ventricular Pacemaker LeadGeorg Semmler, Fabian Barbieri, Karin Thudt, et al.
Journal of Personalized Medicine|April 3, 2021
PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary CenterGeorg Semmler, Lorenz Balcar, Hannes Oberkofler, et al.
Endocrine|September 16, 2025
Association of leptin levels and relative leptin deficiency with steatotic liver disease in the general populationBernhard Wernly, Marianna Beghini, Georg Semmler, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 15, 2021
PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary centerLorenz Balcar, Georg Semmler, Hannes Oberkofler, et al.
Open Heart|March 12, 2026
Association of Life's Simple 7 with metabolic-associated steatotic liver disease and non-invasive fibrosis markersHannah Hofer, Sarah Wernly, Georg Semmler, et al.
Plos One|April 13, 2021
Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver diseaseMichael Eder, Haris Omic, Jana Gorges, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2020
Sequential systemic treatment in patients with hepatocellular carcinomaMartha M Kirstein, Bernhard Scheiner, Tristan Marwede, et al.
Hepatology International|February 9, 2024
FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defenceBenedikt Simbrunner, Benedikt S Hofer, Philipp Schwabl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2023
Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosisBenedikt Silvester Hofer, Benedikt Simbrunner, Lukas Hartl, et al.
Nutrients|July 11, 2023
Inadequate Energy Delivery Is Frequent among COVID-19 Patients Requiring ECMO Support and Associated with Increased ICU MortalityMathias Schneeweiss-Gleixner, Bernhard Scheiner, Georg Semmler, et al.
Pageof 20